Quick Answer
LifeMD, Inc. reported Total Revenue of $212.45 million for fiscal year 2024.
LifeMD, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | $212.45M +39.3% |
$152.55M +28.2% |
$119.03M +28.2% |
$92.88M +149.0% |
$37.29M +199.1% |
| Revenue (ASC 606) | — | $212.45M +39.3% |
$152.55M +28.2% |
$119.03M +28.2% |
$92.88M +149.0% |
$37.29M +199.1% |
| Net Income | $14.35M +167.0% |
-$21.41M -3.9% |
-$20.60M +54.8% |
-$45.54M +25.2% |
-$60.90M -3.8% |
-$58.65M -1769.4% |
| Diluted EPS | — | — | — | — | — | — |
| Total Assets | $70.41M -7.5% |
$76.10M +30.1% |
$58.48M +127.9% |
$25.67M -48.6% |
$49.92M +272.5% |
$13.40M +288.9% |
| Cash and Equivalents | — | $35.00M +5.6% |
$33.15M +737.3% |
$3.96M -90.4% |
$41.33M +350.2% |
$9.18M +729.5% |
| Stockholders Equity | $23.16M +354.9% |
-$9.08M -359.1% |
$3.51M +130.8% |
-$11.40M -150.1% |
$22.74M +1087.9% |
-$2.30M -132.9% |
| R&D Expense | — | — | — | — | — | — |
| Operating Income | — | -$16.14M -11.4% |
-$14.49M +66.7% |
-$43.45M +20.0% |
-$54.30M +6.1% |
-$57.82M -1900.9% |
| Gross Profit | — | $188.39M +41.0% |
$133.65M +33.2% |
$100.37M +34.0% |
$74.88M +163.4% |
$28.43M +185.9% |
| Shares Outstanding | — | 42.19M +10.3% |
38.26M +21.6% |
31.45M +2.8% |
30.60M +31.2% |
23.33M +120.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $60.17M | +13.0% | -4.0% |
| Revenue (ASC 606) | September 30, 2025 | $60.17M | +13.0% | -4.0% |
| Net Income | September 30, 2025 | -$3.81M | +18.3% | -135.0% |
| Diluted EPS | September 30, 2017 | -$0.02 | -100.0% | -200.0% |
| Total Assets | September 30, 2025 | $65.98M | -9.1% | -10.3% |
| Cash and Equivalents | June 30, 2025 | $36.23M | +1.5% | +5.3% |
| Long-Term Debt | September 30, 2021 | $10.82M | — | +16.9% |
| Stockholders Equity | September 30, 2025 | $1.31M | +117.0% | +173.7% |
| Operating Income | September 30, 2025 | -$1.97M | +50.7% | -336.1% |
| Gross Profit | September 30, 2025 | $52.76M | +9.3% | -4.5% |
| Shares Outstanding | September 30, 2025 | 46.58M | +11.4% | +3.4% |
- LifeMD, Inc. reported Total Revenue of $212.45 million for fiscal year 2024.
- LifeMD, Inc. showed an increase of +39.3% in Total Revenue compared to the prior fiscal year.
- LifeMD, Inc. reported Revenue (ASC 606) of $212.45 million for fiscal year 2024.
- LifeMD, Inc. showed an increase of +39.3% in Revenue (ASC 606) compared to the prior fiscal year.
- LifeMD, Inc. reported Net Income of $14.35 million for fiscal year 2025.
- LifeMD, Inc. showed an increase of +167.0% in Net Income compared to the prior fiscal year.
- LifeMD, Inc. reported Diluted EPS of $0.03 per share (loss) for fiscal year 2017.
- LifeMD, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- LifeMD, Inc. reported Total Assets of $70.41 million for fiscal year 2025.
- LifeMD, Inc. showed a decrease of -7.5% in Total Assets compared to the prior fiscal year.
- LifeMD, Inc. reported Cash and Equivalents of $35.00 million for fiscal year 2024.
- LifeMD, Inc. showed an increase of +5.6% in Cash and Equivalents compared to the prior fiscal year.
- LifeMD, Inc. reported Stockholders Equity of $23.16 million for fiscal year 2025.
- LifeMD, Inc. showed an increase of +354.9% in Stockholders Equity compared to the prior fiscal year.
- LifeMD, Inc. reported R&D Expense of $23.9 thousand for fiscal year 2015.
- LifeMD, Inc. reported Operating Income of -$16.14 million for fiscal year 2024.
- LifeMD, Inc. showed a decrease of -11.4% in Operating Income compared to the prior fiscal year.
- LifeMD, Inc. reported Gross Profit of $188.39 million for fiscal year 2024.
- LifeMD, Inc. showed an increase of +41.0% in Gross Profit compared to the prior fiscal year.
- LifeMD, Inc. reported Shares Outstanding of 42.19 million shares for fiscal year 2024.
- LifeMD, Inc. showed an increase of +10.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: